203 related articles for article (PubMed ID: 36802489)
1. Reactive Oxygen Species-Responsive Transformable and Triple-Targeting Butylphthalide Nanotherapy for Precision Treatment of Ischemic Stroke by Normalizing the Pathological Microenvironment.
Yang Q; Pu W; Hu K; Hu Y; Feng Z; Cai J; Li C; Li L; Zhou Z; Zhang J
ACS Nano; 2023 Mar; 17(5):4813-4833. PubMed ID: 36802489
[TBL] [Abstract][Full Text] [Related]
2. A pH/ROS dual-responsive and targeting nanotherapy for vascular inflammatory diseases.
Zhang R; Liu R; Liu C; Pan L; Qi Y; Cheng J; Guo J; Jia Y; Ding J; Zhang J; Hu H
Biomaterials; 2020 Feb; 230():119605. PubMed ID: 31740099
[TBL] [Abstract][Full Text] [Related]
3. Targeted Treatment of Ischemic Stroke by Bioactive Nanoparticle-Derived Reactive Oxygen Species Responsive and Inflammation-Resolving Nanotherapies.
Yuan J; Li L; Yang Q; Ran H; Wang J; Hu K; Pu W; Huang J; Wen L; Zhou L; Jiang Y; Xiong X; Zhang J; Zhou Z
ACS Nano; 2021 Oct; 15(10):16076-16094. PubMed ID: 34606239
[TBL] [Abstract][Full Text] [Related]
4. Novel brain-targeting 3-n-butylphthalide prodrugs for ischemic stroke treatment.
Xiang H; Zhang Q; Han Y; Yang L; Zhang Y; Liu Q; Zhang Z; Zhang L
J Control Release; 2021 Jul; 335():498-514. PubMed ID: 34087248
[TBL] [Abstract][Full Text] [Related]
5. Bioengineered Boronic Ester Modified Dextran Polymer Nanoparticles as Reactive Oxygen Species Responsive Nanocarrier for Ischemic Stroke Treatment.
Lv W; Xu J; Wang X; Li X; Xu Q; Xin H
ACS Nano; 2018 Jun; 12(6):5417-5426. PubMed ID: 29869497
[TBL] [Abstract][Full Text] [Related]
6. 3-
Chen N; Zhou Z; Li J; Li B; Feng J; He D; Luo Y; Zheng X; Luo J; Zhang J
Drug Des Devel Ther; 2018; 12():4261-4271. PubMed ID: 30587922
[TBL] [Abstract][Full Text] [Related]
7. Rapid and improved oral absorption of N-butylphthalide by sodium cholate-appended liposomes for efficient ischemic stroke therapy.
Zhang A; Li J; Wang S; Xu Y; Li Q; Wu Z; Wang C; Meng H; Zhang J
Drug Deliv; 2021 Dec; 28(1):2469-2479. PubMed ID: 34766542
[TBL] [Abstract][Full Text] [Related]
8. L-3-n-Butylphthalide reduces ischemic stroke injury and increases M2 microglial polarization.
Li F; Ma Q; Zhao H; Wang R; Tao Z; Fan Z; Zhang S; Li G; Luo Y
Metab Brain Dis; 2018 Dec; 33(6):1995-2003. PubMed ID: 30117100
[TBL] [Abstract][Full Text] [Related]
9. DL-3-n-butylphthalide prevents neuronal cell death after focal cerebral ischemia in mice via the JNK pathway.
Li J; Li Y; Ogle M; Zhou X; Song M; Yu SP; Wei L
Brain Res; 2010 Nov; 1359():216-26. PubMed ID: 20800583
[TBL] [Abstract][Full Text] [Related]
10. A Targeting Nanotherapy for Abdominal Aortic Aneurysms.
Cheng J; Zhang R; Li C; Tao H; Dou Y; Wang Y; Hu H; Zhang J
J Am Coll Cardiol; 2018 Nov; 72(21):2591-2605. PubMed ID: 30466517
[TBL] [Abstract][Full Text] [Related]
11. Protective multi‑target effects of DL‑3‑n‑butylphthalide combined with 3‑methyl‑1‑phenyl‑2‑pyrazolin‑5‑one in mice with ischemic stroke.
Guan Y; Li P; Liu Y; Guo L; Wu Q; Cheng Y
Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643246
[TBL] [Abstract][Full Text] [Related]
12. Dl-3-N-Butylphthalide Alleviates the Blood-Brain Barrier Permeability of Focal Cerebral Ischemia Reperfusion in Mice.
Li J; Liu Y; Zhang X; Chen R; Zhang L; Xue J; Gao X
Neuroscience; 2019 Aug; 413():99-107. PubMed ID: 31247236
[TBL] [Abstract][Full Text] [Related]
13. Stepwise targeted strategies for improving neurological function by inhibiting oxidative stress levels and inflammation following ischemic stroke.
Li Y; Liao J; Xiong L; Xiao Z; Ye F; Wang Y; Chen T; Huang L; Chen M; Chen ZS; Wang T; Zhang C; Lu Y
J Control Release; 2024 Apr; 368():607-622. PubMed ID: 38423472
[TBL] [Abstract][Full Text] [Related]
14. Sulfated Polysaccharide-Based Nanocarrier Drives Microenvironment-Mediated Cerebral Neurovascular Remodeling for Ischemic Stroke Treatment.
Cao Y; Yu Y; Pan L; Han W; Zeng F; Wang J; Mei Q; Liu C
Nano Lett; 2024 May; 24(17):5214-5223. PubMed ID: 38649327
[TBL] [Abstract][Full Text] [Related]
15. Cerium oxide nanoparticles with antioxidative neurorestoration for ischemic stroke.
Li X; Han Z; Wang T; Ma C; Li H; Lei H; Yang Y; Wang Y; Pei Z; Liu Z; Cheng L; Chen G
Biomaterials; 2022 Dec; 291():121904. PubMed ID: 36403323
[TBL] [Abstract][Full Text] [Related]
16. Dl-3-n-butylphthalide promotes angiogenesis in ischemic stroke mice through upregulating autocrine and paracrine sonic hedgehog.
Dai MJ; Gui XX; Jia SM; Lv ST; Dou H; Cui W
Acta Pharmacol Sin; 2023 Dec; 44(12):2404-2417. PubMed ID: 37580491
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects and molecular mechanisms of DL-3-n-butylphthalide combined with dual antiplatelet therapy in acute ischemic stroke.
Du Y; Li L; Li X; Tan J; Qin Y; Lv Y; Zhai X
Int Immunopharmacol; 2024 Mar; 129():111592. PubMed ID: 38295546
[TBL] [Abstract][Full Text] [Related]
18. Remodeling brain pathological microenvironment to lessen cerebral ischemia injury by multifunctional injectable hydrogels.
Zhang W; Liu Y; Wang Z; He S; Liu W; Wu Y; Yang L; Hu C; Wang Y
J Control Release; 2024 May; 369():591-603. PubMed ID: 38582336
[TBL] [Abstract][Full Text] [Related]
19. A Multifunctional Nanotherapy for Targeted Treatment of Colon Cancer by Simultaneously Regulating Tumor Microenvironment.
Zhang Q; Zhang F; Li S; Liu R; Jin T; Dou Y; Zhou Z; Zhang J
Theranostics; 2019; 9(13):3732-3753. PubMed ID: 31281510
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Review of Neuroprotective Efficacy and Safety of DL-3-N-Butylphthalide in Ischemic Stroke.
Xu ZQ; Zhou Y; Shao BZ; Zhang JJ; Liu C
Am J Chin Med; 2019; 47(3):507-525. PubMed ID: 30966774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
